世界の単核球症診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Mononucleosis Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3912 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、単核球症診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノスポット検査、全血球計算検査、エプスタインバーウイルス（EBV）抗体検査）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・単核球症診断の市場動向 ・企業の競争状況、市場シェア ・単核球症診断の種類別市場規模（モノスポット検査、全血球計算検査、エプスタインバーウイルス（EBV）抗体検査） ・単核球症診断の用途別市場規模（病院、研究所、その他） ・単核球症診断の北米市場規模2016-2027（アメリカ、カナダ） ・単核球症診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・単核球症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・単核球症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・単核球症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、ELITechGroup、Beckman Coulter、Bio-Rad Laboratories、Cardinal Health、Immunostics、Meridian Bioscience、Quidel Corporation、Sekisui Diagnostics、Thermo Fischer Scientific、Siemens、Biomerieux） ・結論

Mononucleosis (infection) is an acute, self-limited Infectious disease caused by EBV (a contagious virus, Epstein-Barr) . The clinical features were fever, Laryngitis, Hepatosplenomegaly, abnormal blood lymphocyte, abnormal lymphocyte, positive hetero-agglutination test and anti-EBV antibody in Vivo after infection. Adolescents and young adults (12 to 40 years old) are more likely to be affected.

Market Analysis and Insights: Global Mononucleosis Diagnostic Market
The global Mononucleosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mononucleosis Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mononucleosis Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mononucleosis Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mononucleosis Diagnostic market.

Global Mononucleosis Diagnostic Scope and Market Size
Mononucleosis Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mononucleosis Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monospot Test
Complete Blood Count Test
Epstein Barr Virus (EBV) Antibody Test

Segment by Application
Hospitals
Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
ELITechGroup
Beckman Coulter
Bio-Rad Laboratories
Cardinal Health
Immunostics
Meridian Bioscience
Quidel Corporation
Sekisui Diagnostics
Bio-Rad Laboratories

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monospot Test
1.2.3 Complete Blood Count Test
1.2.4 Epstein Barr Virus (EBV) Antibody Test
1.3 Market by Application
1.3.1 Global Mononucleosis Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mononucleosis Diagnostic Market Perspective (2016-2027)
2.2 Mononucleosis Diagnostic Growth Trends by Regions
2.2.1 Mononucleosis Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mononucleosis Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Mononucleosis Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Mononucleosis Diagnostic Industry Dynamic
2.3.1 Mononucleosis Diagnostic Market Trends
2.3.2 Mononucleosis Diagnostic Market Drivers
2.3.3 Mononucleosis Diagnostic Market Challenges
2.3.4 Mononucleosis Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mononucleosis Diagnostic Players by Revenue
3.1.1 Global Top Mononucleosis Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Mononucleosis Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Mononucleosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mononucleosis Diagnostic Revenue
3.4 Global Mononucleosis Diagnostic Market Concentration Ratio
3.4.1 Global Mononucleosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mononucleosis Diagnostic Revenue in 2020
3.5 Mononucleosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Mononucleosis Diagnostic Product Solution and Service
3.7 Date of Enter into Mononucleosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mononucleosis Diagnostic Breakdown Data by Type
4.1 Global Mononucleosis Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Mononucleosis Diagnostic Forecasted Market Size by Type (2022-2027)

5 Mononucleosis Diagnostic Breakdown Data by Application
5.1 Global Mononucleosis Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Mononucleosis Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mononucleosis Diagnostic Market Size (2016-2027)
6.2 North America Mononucleosis Diagnostic Market Size by Type
6.2.1 North America Mononucleosis Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Mononucleosis Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Mononucleosis Diagnostic Market Size by Type (2016-2027)
6.3 North America Mononucleosis Diagnostic Market Size by Application
6.3.1 North America Mononucleosis Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Mononucleosis Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Mononucleosis Diagnostic Market Size by Application (2016-2027)
6.4 North America Mononucleosis Diagnostic Market Size by Country
6.4.1 North America Mononucleosis Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Mononucleosis Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Mononucleosis Diagnostic Market Size (2016-2027)
7.2 Europe Mononucleosis Diagnostic Market Size by Type
7.2.1 Europe Mononucleosis Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Mononucleosis Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Mononucleosis Diagnostic Market Size by Type (2016-2027)
7.3 Europe Mononucleosis Diagnostic Market Size by Application
7.3.1 Europe Mononucleosis Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Mononucleosis Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Mononucleosis Diagnostic Market Size by Application (2016-2027)
7.4 Europe Mononucleosis Diagnostic Market Size by Country
7.4.1 Europe Mononucleosis Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Mononucleosis Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mononucleosis Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type
8.2.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Application
8.3.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Mononucleosis Diagnostic Market Size by Region
8.4.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mononucleosis Diagnostic Market Size (2016-2027)
9.2 Latin America Mononucleosis Diagnostic Market Size by Type
9.2.1 Latin America Mononucleosis Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Mononucleosis Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Mononucleosis Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Mononucleosis Diagnostic Market Size by Application
9.3.1 Latin America Mononucleosis Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Mononucleosis Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Mononucleosis Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Mononucleosis Diagnostic Market Size by Country
9.4.1 Latin America Mononucleosis Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Mononucleosis Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mononucleosis Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type
10.2.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application
10.3.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Mononucleosis Diagnostic Market Size by Country
10.4.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Mononucleosis Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 ELITechGroup
11.2.1 ELITechGroup Company Details
11.2.2 ELITechGroup Business Overview
11.2.3 ELITechGroup Mononucleosis Diagnostic Introduction
11.2.4 ELITechGroup Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.2.5 ELITechGroup Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Mononucleosis Diagnostic Introduction
11.3.4 Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.3.5 Beckman Coulter Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Mononucleosis Diagnostic Introduction
11.5.4 Cardinal Health Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.5.5 Cardinal Health Recent Development
11.6 Immunostics
11.6.1 Immunostics Company Details
11.6.2 Immunostics Business Overview
11.6.3 Immunostics Mononucleosis Diagnostic Introduction
11.6.4 Immunostics Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.6.5 Immunostics Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Mononucleosis Diagnostic Introduction
11.7.4 Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.7.5 Meridian Bioscience Recent Development
11.8 Quidel Corporation
11.8.1 Quidel Corporation Company Details
11.8.2 Quidel Corporation Business Overview
11.8.3 Quidel Corporation Mononucleosis Diagnostic Introduction
11.8.4 Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.8.5 Quidel Corporation Recent Development
11.9 Sekisui Diagnostics
11.9.1 Sekisui Diagnostics Company Details
11.9.2 Sekisui Diagnostics Business Overview
11.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Introduction
11.9.4 Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.9.5 Sekisui Diagnostics Recent Development
11.10 Thermo Fischer Scientific
11.10.1 Thermo Fischer Scientific Company Details
11.10.2 Thermo Fischer Scientific Business Overview
11.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Introduction
11.10.4 Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.10.5 Thermo Fischer Scientific Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Mononucleosis Diagnostic Introduction
11.11.4 Siemens Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.11.5 Siemens Recent Development
11.12 Biomerieux
11.12.1 Biomerieux Company Details
11.12.2 Biomerieux Business Overview
11.12.3 Biomerieux Mononucleosis Diagnostic Introduction
11.12.4 Biomerieux Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.12.5 Biomerieux Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mononucleosis Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monospot Test
Table 3. Key Players of Complete Blood Count Test
Table 4. Key Players of Epstein Barr Virus (EBV) Antibody Test
Table 5. Global Mononucleosis Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Mononucleosis Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Mononucleosis Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Mononucleosis Diagnostic Market Share by Regions (2016-2021)
Table 9. Global Mononucleosis Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Mononucleosis Diagnostic Market Share by Regions (2022-2027)
Table 11. Mononucleosis Diagnostic Market Trends
Table 12. Mononucleosis Diagnostic Market Drivers
Table 13. Mononucleosis Diagnostic Market Challenges
Table 14. Mononucleosis Diagnostic Market Restraints
Table 15. Global Mononucleosis Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Mononucleosis Diagnostic Market Share by Players (2016-2021)
Table 17. Global Top Mononucleosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mononucleosis Diagnostic as of 2020)
Table 18. Ranking of Global Top Mononucleosis Diagnostic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Mononucleosis Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Mononucleosis Diagnostic Product Solution and Service
Table 22. Date of Enter into Mononucleosis Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mononucleosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Mononucleosis Diagnostic Revenue Market Share by Type (2016-2021)
Table 26. Global Mononucleosis Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Mononucleosis Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Mononucleosis Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Mononucleosis Diagnostic Revenue Market Share by Application (2016-2021)
Table 30. Global Mononucleosis Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Mononucleosis Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Mononucleosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Mononucleosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Mononucleosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Mononucleosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Mononucleosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Mononucleosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Mononucleosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Mononucleosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Mononucleosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Mononucleosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Mononucleosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Mononucleosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Mononucleosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Mononucleosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Mononucleosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Mononucleosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Mononucleosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Mononucleosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Mononucleosis Diagnostic Product
Table 65. Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. ELITechGroup Company Details
Table 68. ELITechGroup Business Overview
Table 69. ELITechGroup Mononucleosis Diagnostic Product
Table 70. ELITechGroup Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 71. ELITechGroup Recent Development
Table 72. Beckman Coulter Company Details
Table 73. Beckman Coulter Business Overview
Table 74. Beckman Coulter Mononucleosis Diagnostic Product
Table 75. Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 76. Beckman Coulter Recent Development
Table 77. Bio-Rad Laboratories Company Details
Table 78. Bio-Rad Laboratories Business Overview
Table 79. Bio-Rad Laboratories Mononucleosis Diagnostic Product
Table 80. Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 81. Bio-Rad Laboratories Recent Development
Table 82. Cardinal Health Company Details
Table 83. Cardinal Health Business Overview
Table 84. Cardinal Health Mononucleosis Diagnostic Product
Table 85. Cardinal Health Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 86. Cardinal Health Recent Development
Table 87. Immunostics Company Details
Table 88. Immunostics Business Overview
Table 89. Immunostics Mononucleosis Diagnostic Product
Table 90. Immunostics Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 91. Immunostics Recent Development
Table 92. Meridian Bioscience Company Details
Table 93. Meridian Bioscience Business Overview
Table 94. Meridian Bioscience Mononucleosis Diagnostic Product
Table 95. Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 96. Meridian Bioscience Recent Development
Table 97. Quidel Corporation Company Details
Table 98. Quidel Corporation Business Overview
Table 99. Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 100. Quidel Corporation Recent Development
Table 101. Sekisui Diagnostics Company Details
Table 102. Sekisui Diagnostics Business Overview
Table 103. Sekisui Diagnostics Mononucleosis Diagnostic Product
Table 104. Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 105. Sekisui Diagnostics Recent Development
Table 106. Thermo Fischer Scientific Company Details
Table 107. Thermo Fischer Scientific Business Overview
Table 108. Thermo Fischer Scientific Mononucleosis Diagnostic Product
Table 109. Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 110. Thermo Fischer Scientific Recent Development
Table 111. Siemens Company Details
Table 112. Siemens Business Overview
Table 113. Siemens Mononucleosis Diagnostic Product
Table 114. Siemens Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 115. Siemens Recent Development
Table 116. Biomerieux Company Details
Table 117. Biomerieux Business Overview
Table 118. Biomerieux Mononucleosis Diagnostic Product
Table 119. Biomerieux Revenue in Mononucleosis Diagnostic Business (2016-2021) & (US$ Million)
Table 120. Biomerieux Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mononucleosis Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Monospot Test Features
Figure 3. Complete Blood Count Test Features
Figure 4. Epstein Barr Virus (EBV) Antibody Test Features
Figure 5. Global Mononucleosis Diagnostic Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Laboratories Case Studies
Figure 8. Others Case Studies
Figure 9. Mononucleosis Diagnostic Report Years Considered
Figure 10. Global Mononucleosis Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Mononucleosis Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Mononucleosis Diagnostic Market Share by Regions: 2020 VS 2027
Figure 13. Global Mononucleosis Diagnostic Market Share by Regions (2022-2027)
Figure 14. Global Mononucleosis Diagnostic Market Share by Players in 2020
Figure 15. Global Top Mononucleosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mononucleosis Diagnostic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Mononucleosis Diagnostic Revenue in 2020
Figure 17. Global Mononucleosis Diagnostic Revenue Market Share by Type (2016-2021)
Figure 18. Global Mononucleosis Diagnostic Revenue Market Share by Type (2022-2027)
Figure 19. North America Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Mononucleosis Diagnostic Market Share by Type (2016-2027)
Figure 21. North America Mononucleosis Diagnostic Market Share by Application (2016-2027)
Figure 22. North America Mononucleosis Diagnostic Market Share by Country (2016-2027)
Figure 23. United States Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Mononucleosis Diagnostic Market Share by Type (2016-2027)
Figure 27. Europe Mononucleosis Diagnostic Market Share by Application (2016-2027)
Figure 28. Europe Mononucleosis Diagnostic Market Share by Country (2016-2027)
Figure 29. Germany Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Mononucleosis Diagnostic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Mononucleosis Diagnostic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Mononucleosis Diagnostic Market Share by Region (2016-2027)
Figure 39. China Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Mononucleosis Diagnostic Market Share by Type (2016-2027)
Figure 47. Latin America Mononucleosis Diagnostic Market Share by Application (2016-2027)
Figure 48. Latin America Mononucleosis Diagnostic Market Share by Country (2016-2027)
Figure 49. Mexico Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Mononucleosis Diagnostic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Mononucleosis Diagnostic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Mononucleosis Diagnostic Market Share by Country (2016-2027)
Figure 55. Turkey Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Mononucleosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 59. ELITechGroup Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 60. Beckman Coulter Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 62. Cardinal Health Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 63. Immunostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 64. Meridian Bioscience Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 65. Quidel Corporation Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 66. Sekisui Diagnostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 67. Thermo Fischer Scientific Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 68. Siemens Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 69. Biomerieux Revenue Growth Rate in Mononucleosis Diagnostic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---